Entelmed

— WHAT WE DO

One company across the
musculoskeletal continuum

Orthopedics

Comprehensive solutions for joint reconstruction and trauma.

Sports Medicine

Advanced soft tissue repair and minimally invasive interventions.

Biologics & Regeneration

Next-generation orthobiologics accelerating the body's healing potential.

AI & Advanced Technology

SurgiSync™ platform connecting data across the continuum of care.

— WHO WE SERVE

Built for every touchpoint in
musculoskeletal care

From the OR to the ambulatory suite, EntelMed equips the full care team with products, data, and support they can rely on for years — not quarters.

Surgeons

Hospitals

Surgery Centers

Health Systems

TECHNOLOGY

Where data from every
procedure makes the
next one smarter

Most companies in this field do one thing. EntelMed is building something broader — a platform where clinical products, regenerative science, and artificial intelligence reinforce one another, generating a data flywheel that compounds over time.

Explore technology →

AI & Machine Learning

Surgical intelligence that learns from procedure data — improving guidance, outcome prediction, and implant selection over time.

IN DEVELOPMENT

SurgiSync™ Platform

An integrated surgical planning and navigation platform connecting pre-op imaging, intraoperative guidance, and post-op tracking.

IN DEVELOPMENT

Cutting-Edge Technologies

Robotics, computer vision, and advanced materials research — building tomorrow's surgical toolkit in partnership with academic and clinical leaders.

Data Continuum

Every product sold and every procedure performed contributes to a growing clinical dataset — the foundation for smarter decisions across the continuum.

Regen
Medicine

Stem
Cell
Therapy

Bone
Graft

PRP
Therapy

Growth
Factors

Scaffold
Tech

Cartilage
Repair

Tissue
Engineering

Cell
Therapy

BIOLOGICS & REGENERATION

The body's own
healing potential,
amplified

Bone grafts & substrates

Structural and resorbable grafts for fusion, void filling, and augmentation across spinal and orthopedic procedures.
Emerging cell-based therapies

Next-generation treatments that leverage the body's regenerative mechanisms — in active scientific development.
Integrated with the clinical product line

Biologics and implants designed to work together — one company, one relationship, seamless delivery.

Explore biologics →

OUR PHILOSOPHY

Built to last

We own our companies for the long term — giving surgeons, hospitals, and our own teams something rare in this industry: continuity, and a partner whose plans are measured in decades, not exit timelines.

Long-term ownership

No private equity churn, no quarterly pressure to exit. We build for the decade, not the next board meeting.

Surgeon continuity

The rep you work with today is the rep you'll work with in five years. Relationships aren't disrupted by acquisitions.

Domestic & independent

Affiliated with Cebron Financial Group. Domestically owned and operated — accountable to our partners, not to foreign shareholders.

— LEADERSHIP

The team behind
the mission

Clinical Excellence

Medical & Scientific Advisory

Guided by leading surgeons pushing the boundaries of musculoskeletal care.

Technology Leadership

Engineering & AI

Experts from top-tier tech and medtech companies building the SurgiSync platform.

Commercial Operations

Sales & Execution

Decades of experience delivering reliable solutions to health systems globally.

PARTNER WITH ENTELMED

Ready to build
something lasting?

We're looking for surgeon partners, health system relationships, and acquisition opportunities that fit our long-term vision. If you share our commitment to musculoskeletal health, let's talk.

Partner with us → Contact us

Surgeon partnerships

Collaborate on clinical product development, early access to emerging technologies, and outcomes research.

Health system agreements

Standardization programs, preferred pricing, and a single-source solution across orthopedics, sports medicine, and biologics.

Acquisition opportunities

We acquire companies for the long term. If you're considering an exit, we offer continuity, culture preservation, and fair value.

One company across themusculoskeletal continuum